Some people lose far more weight than others on GLP-1s like Wegovy. Here’s why.

AI Summary

Emerging studies reveal significant variability in weight loss effects among individuals using GLP-1 drugs like Wegovy. Research indicates the presence of 'super-responders' alongside those with minimal or no response.

Emerging research shows there are 'super-responders' to GLP-1 drugs, and others who don't respond at all.